MediciNova, Inc. (MNOV)
1.78
+0.03
(+1.71%)
USD |
NASDAQ |
Sep 09, 15:46
MediciNova Shareholders Equity (Quarterly) : 37.27M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.27M |
| March 31, 2026 | 39.41M |
| December 31, 2025 | 41.59M |
| September 30, 2025 | 43.96M |
| June 30, 2025 | 46.86M |
| March 31, 2025 | 49.93M |
| December 31, 2024 | 52.50M |
| September 30, 2024 | 55.07M |
| June 30, 2024 | 57.41M |
| March 31, 2024 | 59.83M |
| December 31, 2023 | 62.38M |
| September 30, 2023 | 64.67M |
| June 30, 2023 | 65.18M |
| March 31, 2023 | 67.73M |
| December 31, 2022 | 70.24M |
| September 30, 2022 | 73.11M |
| June 30, 2022 | 76.61M |
| March 31, 2022 | 80.36M |
| December 31, 2021 | 83.68M |
| September 30, 2021 | 86.48M |
| June 30, 2021 | 89.23M |
| March 31, 2021 | 92.37M |
| December 31, 2020 | 71.33M |
| September 30, 2020 | 73.55M |
| June 30, 2020 | 71.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 73.20M |
| December 31, 2019 | 74.89M |
| September 30, 2019 | 74.35M |
| June 30, 2019 | 73.18M |
| March 31, 2019 | 75.04M |
| December 31, 2018 | 73.11M |
| September 30, 2018 | 73.55M |
| June 30, 2018 | 75.59M |
| March 31, 2018 | 75.57M |
| December 31, 2017 | 38.64M |
| September 30, 2017 | 34.72M |
| June 30, 2017 | 33.39M |
| March 31, 2017 | 32.75M |
| December 31, 2016 | 34.53M |
| September 30, 2016 | 35.75M |
| June 30, 2016 | 37.37M |
| March 31, 2016 | 39.14M |
| December 31, 2015 | 32.75M |
| September 30, 2015 | 34.63M |
| June 30, 2015 | 19.95M |
| March 31, 2015 | 20.95M |
| December 31, 2014 | 22.01M |
| September 30, 2014 | 22.98M |
| June 30, 2014 | 24.80M |
| March 31, 2014 | 26.65M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.43M |
| Total Liabilities (Quarterly) | 3.163M |
| Debt to Equity Ratio | 0.0031 |
| Current Ratio | 8.754 |
| Net Debt Paydown Yield | 0.07% |